Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases

2018/04/12 by Julien Kirchgesner, Magali Lemaitre, Magali Lemaître +5 · 26 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Inflammatory Bowel Disease #Rheumatoid Arthritis Research and Therapies #Clostridium difficile and Clostridium perfringens research

paper · pdf · doi:10.1053/j.gastro.2018.04.012

Citations

• Constructing Inverse Probability Weights for Marginal Structural Models

Cited by

• AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease
• Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease. [europepmc]
• Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. [europepmc]
• A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease. [europepmc]
• AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis. [europepmc]
• Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study. [europepmc]
• Uneventful Course in Patients With Inflammatory Bowel Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak in Northern Italy. [europepmc]
• Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain). [europepmc]
• Review article: prevention, diagnosis and management of COVID-19 in the IBD patient. [europepmc]
• Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts. [europepmc]
• Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. [europepmc]
• Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines. [europepmc]
• Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn's disease. [europepmc]
• Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF? [europepmc]
• Effect of IBD medications on COVID-19 outcomes: results from an international registry. [europepmc]
• Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta-analysis. [europepmc]
• SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement. [europepmc]
• Use of thiopurines in inflammatory bowel disease: an update. [europepmc]
• Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. [europepmc]
• Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications. [europepmc]
• AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease. [europepmc]
• Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study. [europepmc]
• Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis. [europepmc]
• Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19. [europepmc]
• Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases. [europepmc]
• Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review. [europepmc]